1,239
Views
21
CrossRef citations to date
0
Altmetric
Review

The pharmacological management of dental pain

, , , &
Pages 591-601 | Received 30 Oct 2019, Accepted 16 Jan 2020, Published online: 06 Feb 2020

References

  • Cooper SA, Desjardins PJ, Turk DC, et al. Research design considerations for single-dose analgesic clinical trials in acute pain: IMMPACT recommendations. Pain. 2016 Feb;157(2):288–301.
  • Cooper S, Desjardin P. The value of the dental impaction pain model in drug development. Methods Molecular Biology. 2010;617:175–190.
  • Urquhart E. Analgesic agents and strategies in the dental pain model. J Dent. 1994;22(6):336–341.
  • Slika R. Acetaminophen. In: Elzouki AY, Harfi HA, Nazer HM, Stapleton FB, Oh W, Whitley RJ, editors. Textbook of clinical pediatrics. Berlin, Heidelberg: Springer; 2012. p. 2593–2595.
  • Hanel A, Lands W. Modification of anti-inflammatory drug effectiveness by ambient lipid peroxides. Biochem Pharmacol. 1982;31:3307–3311.
  • Aminoshariae A, Khan A. Acetaminophen: old drug, new issues. J Endod. 2015 May;41(5):588–593.
  • Botting RM. Mechanism of action of acetaminophen: is there a cyclooxygenase 3? Clin Infect Dis. 2000 October;31(Suppl 5):S202–10.
  • Renner B, Clarke G, Grattan T, et al. Caffeine accelerates absorption and enhances the analgesic effect of acetaminophen. J Clin Pharmacol. 2007 June 01;47(6):715–726.
  • Mallet C, Barriere DA, Ermund A, et al. TRPV1 in brain is involved in acetaminophen-induced antinociception. PLoS One. 2010 Sep 17;5(9):e12748.
  • Jensen MS, Rebordosa C, Thulstrup AM, et al. Maternal use of acetaminophen, ibuprofen, and acetylsalicylic acid during pregnancy and risk of cryptorchidism. Epidemiology. 2010 Nov;21(6):779–785.
  • Prescott LF. Kinetics and metabolism of paracetamol and phenacetin. Br J Clin Pharmacol. 1980 Oct;10(Suppl 2):291s–298s.
  • Qi DS, May LG, Zimmerman B, et al. A randomized, double-blind, placebo-controlled study of acetaminophen 1000 mg versus acetaminophen 650 mg for the treatment of postsurgical dental pain. Clin Ther. 2012 December;34(12):pp2247–2258e3.
  • Barkin RL, Beckerman ML, Blum SM, et al. Should nonsteroidal anti-inflammatory drugs (NSAIDs) be prescribed to the older adult? Drugs Aging. 2010;27(10):775–789.
  • The mechanisms of action of NSAIDs in analgesia. 1996; In: Cashman J, Caldwell J, editors.
  • van der Linden MW, van der Bij S, Welsing P, et al. The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugs. Ann Rheum Dis. 2009 May;68(5):668–673.
  • Osafo N, Agyare C, Obiri D, et al. Mechanism of action of nonsteroidal anti-inflammatory drugs. In: Al-kaf A, editor. Nonsteroidal anti-inflammatory drugs. Intech Open; 2017. Available from: https://www.intechopen.com/books/nonsteroidal-anti-inflammatory-drugs/mechanism-of-action-of-nonsteroidal-anti-inflammatory-drugs
  • Conaghan PG. A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity. Rheumatol Int. 2012;32(6):1491–1502.
  • Laurora I, An R. Efficacy of single-dose, extended-release naproxen sodium 660 mg in postsurgical dental pain: two double-blind, randomized, placebo-controlled trials. Curr Med Res Opin. 2016 February 01;32(2):331–342.
  • Cooper SA, Desjardins P, Brain P, et al. Longer analgesic effect with naproxen sodium than ibuprofen in post-surgical dental pain: a randomized, double-blind, placebo-controlled, single-dose trial. Curr Med Res Opin. 2019 August 27;35(12):1–10.
  • Christensen S, Paluch E, Jayawardena S, et al. Analgesic efficacy of a new immediate‐release/extended‐release formulation of ibuprofen: results from single‐ and multiple‐dose postsurgical dental pain studies. Clin Pharmacol Drug Dev. 2017 May;6(3):302–312.
  • Sultan A, McQuay HJ, Moore RA, et al. Single dose oral flurbiprofen for acute postoperative pain in adults. Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007358. doi: 10.1002/14651858.CD007358.pub2.
  • Highlights of prescribing information: ANSAID (Flurbiprofen). New York, NY: Pfizer; 2016 [cited 2020 Jan 6]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/018766s020lbl.pdf
  • Pathan H, Williams J. Basic opioid pharmacology: an update. Br J Pain. 2012;6(1):11–16.
  • Stein C. Targeting pain and inflammation by peripherally acting opioids. Front Pharmacol. 2013;4:123.
  • DEA. Drug scheduling. Washington, DC: Drug Enforcement Administration; 2019 [cited 2019 Aug 28]. Available from: https://www.dea.gov/drug-scheduling
  • Trescot A, DAtta S, Lee MH, et al. Opioid pharmacology. Pain Physician. 2008;11(2 Suppl):S133–S153.
  • Raffa RB, Haidery M, Huang HM, et al. The clinical analgesic efficacy of buprenorphine. J Clin Pharm Ther. 2014 Dec;39(6):577–583.
  • Dowell D, Haegerich T, Chou R. No shortcuts to safer opioid prescribing. N Engl J Med. 2019 Apr 24;380:2285–2287.
  • Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain–United States, 2016. Jama. 2016 Apr 19;315(15):1624–1645.
  • Lutfiyya MN, Gross AJ, Schvaneveldt N, et al. A scoping review exploring the opioid prescribing practices of US dental professionals. J Am Dent Assoc. 2018 December 01;149(12):1011–1023.
  • Maughan BC, Hersh EV, Shofer FS, et al. Unused opioid analgesics and drug disposal following outpatient dental surgery: a randomized controlled trial. Drug Alcohol Depend. 2016 Nov 1;168:328–334.
  • Suda KJ, Durkin MJ, Calip GS, et al. Comparison of opioid prescribing by dentists in the United States and England. JAMA Network Open. 2019;2(5):e194303–e194303.
  • Baker JA, Avorn J, Levin R, et al. Opioid prescribing after surgical extraction of teeth in medicaid patients, 2000–2010. Jama. 2016 Apr 19;315(15):1653–1654.
  • Kleinert R, Lange C, Steup A, et al. Single dose analgesic efficacy of tapentadol in postsurgical dental pain: the results of a randomized, double-blind, placebo-controlled study. Anesthesia Analg. 2008;107(6):2048–2055.
  • Hersh EV, Golubic S, Moore PA. Analgesic update: tapentadol hydrochloride. Compend Continuing Educ Dent. 2010 October;31(8):594–599. (Jamesburg, NJ: 1995). quiz 600, 603.
  • Silverman RB, Richard BS, Candiotti KA, et al. Tapentadol extended-release: a recent addition to our analgesic armamentarium. Pain Manag. 2012 Sept;2(5):451(6).
  • Wade WE, Spruill WJ. Tapentadol hydrochloride: a centrally acting oral analgesic. Clin Ther. 2009;31(12):2804–2818.
  • Fidman B, Nogid A. Role of tapentadol immediate release (Nucynta) in the management of moderate-to-severe pain. Pharm Ther. 2010;35(6):330–357.
  • Singh DR, Nag K, Shetti AN, et al. Tapentadol hydrochloride: a novel analgesic. Saudi J Anaesth. 2013;7(3):322–326.
  • Christensen SK, Cohen EA, Mermelstein HF, et al. The analgesic efficacy and safety of a novel intranasal morphine formulation (Morphine plus chitosan), immediate release oral morphine, intravenous morphine, and placebo in a postsurgical dental pain model. Anesthesia Analg. 2008;107(6):2018–2024.
  • Denisco RC, Kenna GA, O’Neil MG, et al. Prevention of prescription opioid abuse: the role of the dentist. J Am Dent Assoc. 2011;142(7):800–810.
  • Volkow N, McLellan T. Curtailing diversion and abuse of opioid analgesics without jeopardizing pain treatment. J Am Med Assoc. 2011;13:1346–1347.
  • Vearrier L. What are the ethical considerations when prescribing patients opioid medications for acute dental pain? J Am Dent Assoc. 2019 May 01;150(5):396–397.
  • Harbaugh C, Nalliah R, Hu H, et al. Persistent opioid use after wisdom tooth extraction. J Am Med Assoc. 2018;320(5):504–506.
  • Moore PA, Ziegler KM, Lipman RD, et al. Benefits and harms associated with analgesic medications used in the management of acute dental pain. J Am Dent Assoc. 2018 April;149(4):256–265e3.
  • Tong SE, Daniels SE, Black P, et al. Novel p38-alpha mitogen-activated protein kinase inhibitor shows analgesic efficacy in acute postsurgical dental pain. J Clin Pharmacol. 2012 May;52(5):717–728.
  • Clayton N, Marshall FH, Bountra C, et al. CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain. Pain. 2002 Apr;96(3):253–260.
  • Elmes SJ, Jhaveri MD, Smart D, et al. Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naive rats and in rat models of inflammatory and neuropathic pain. Eur J Neurosci. 2004 Nov;20(9):2311–2320.
  • Rahn EJ, Makriyannis A, Hohmann AG. Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats. Br J Pharmacol. 2007 Nov;152(5):765–777.
  • Ostenfeld FT, Price FJ, Albanese FM, et al. A randomized, controlled study to investigate the analgesic efficacy of single doses of the cannabinoid receptor-2 agonist GW842166, Ibuprofen or placebo in patients with acute pain following third molar tooth extraction. Clin J Pain. 2011;27(8):668–676.
  • Pharmos announces clinical data from phase 2a trial of cannabinor for nociceptive pain in third molar dental extraction model; Analgesic Signal Observed. PR Newswire. 2007 Apr 24.
  • Kean WF. Oxaprozin: kinetic and dynamic profile in the treatment of pain. Curr Med Res Opin. 2004 August 01;20(8):1275–1277.
  • Kara İM, Polat S, İnce F, et al. Analgesic and anti-inflammatory effects of Oxaprozin and naproxen sodium after removal of impacted lower third molars: a randomized, double-blind, placebo-controlled crossover study. J Oral Maxillofacial Surg. 2010;68(5):1018–1024.
  • O’Brien J, Pergolizzi JV Jr., van de Laar M, et al. Fixed-dose combinations at the front line of multimodal pain management: perspective of the nurse-prescriber. (Report). Nurs Res Rev. 2013;3(14):9.
  • Tallarida RJ, Cowan A, Raffa RB. Antinociceptive synergy, additivity, and subadditivity with combinations of oral glucosamine plus nonopioid analgesics in mice. J Pharmacol Exp Ther. 2003 November;307(2):699–704.
  • Daniels SE, Atkinson HC, Stanescu I, et al. Analgesic efficacy of an Acetaminophen/Ibuprofen fixed-dose combination in moderate to severe postoperative dental pain: a randomized, double-blind, parallel-group, placebo-controlled trial. Clin Ther. 2018 October;40(10):1765–1776e5.
  • Mehlisch DR, Aspley S, Daniels SE, et al. Comparison of the analgesic efficacy of concurrent ibuprofen and paracetamol with ibuprofen or paracetamol alone in the management of moderate to severe acute postoperative dental pain in adolescents and adults: a randomized, double-blind, placebo-controlled, parallel-group, single-dose, two-cent. Clin Ther. 2010;32(5):882–895.
  • Moore PA, Hersh EV. Combining ibuprofen and acetaminophen for acute pain management after third-molar extractions. J Am Dent Assoc. 2013 August;144(8):898–908.
  • Macleod AG, Ashford B, Voltz M, et al. Paracetamol versus paracetamol‐codeine in the treatment of post‐operative dental pain: a randomized, double‐blind, prospective trial. Aust Dent J. 2002 June;47(2):147–151.
  • Litkowski LJ, Christensen SE, Adamson DN, et al. Analgesic efficacy and tolerability of oxycodone 5 mg/ibuprofen400 mg compared with those of oxycodone 5 mg/acetaminophen 325 mg and hydrocodone 7.5 mg/acetaminophen 500 mg in patients with moderate to severe postoperative pain: a randomized, double-blind, placebo-controlled, single-dose, parallel-group study in a dental pain model.. Clin Ther. 2005;27(4):418–429.
  • Moore RA, Derry S, Aldington D, et al. Single dose oral analgesics for acute postoperative pain in adults - an overview of Cochrane reviews.. Cochrane Database Syst Rev. 2015 Sep 28;(9):CD008659. doi: 10.1002/14651858.CD008659.pub3.
  • Yue Y, Collaku A, Brown J, et al. Efficacy and speed of onset of pain relief of fast-dissolving paracetamol on postsurgical dental pain: two randomized, single-dose, double-blind, placebo-controlled clinical studies. Clin Ther. 2013 September;35(9):1306–1320.
  • Krishnan S, Sharma P, Sharma R, et al. Transdermal diclofenac patches for control of post-extraction pain. Pilot randomized controlled double-blind study. Oral Maxillofac Surg. 2015 March 01;19(1):5–12.
  • Annigeri R, Rajeshwari A, Jadhav M, et al. Clinical evaluation of transmucosal mucoadhesive meloxicam patch in dental pain reduction: a preliminary study. (original article). Indian J Pain. 2015;29(2):82.
  • Currie CC, Stone SJ, Connolly J, et al. Dental pain in the medical emergency department: a cross‐sectional study. J Oral Rehabil. 2017 February;44(2):105–111.
  • Benko K. Dental pain. In: Mahadevan S, Garmel G, editors. An introduction to clinical emergency medicine. Cambridge, UK: Cambridge University Press; 2012. p. 255-270.
  • Macauley Y, O’donnell P, Duncan HF. Dental pain. BMJ. 2013 November 5;347:f6539.
  • Aminoshariae A, Kulild JC. Evidence-based recommendations for antibiotic usage to treat endodontic infections and pain: a systematic review of randomized controlled trials. J Am Dent Assoc. 2016 Mar;147(3):186–191.
  • Hersh EV, Ciancio SG, Kuperstein AS, et al. An evaluation of 10 percent and 20 percent benzocaine gels in patients with acute toothaches: efficacy, tolerability and compliance with label dose administration directions. J Am Dent Assoc. 2013 May;144(5):517–526.
  • Hersh EV, Stoopler ET, Secreto SA, et al. A study of benzocaine gel dosing for toothache. J Clin Dent. 2005;16(4):103–108.
  • Shepherd SD, O’Buckley SC, Harrington JM, et al. A moldable sustained release bupivacaine formulation for tailored treatment of postoperative dental pain. Sci Rep. 2018 August 15;8(1):12172.
  • Horishita T, Yanagihara N, Ueno S, et al. Antidepressants inhibit Nav1.3, Nav1.7, and Nav1.8 neuronal voltage-gated sodium channels more potently than Nav1.2 and Nav1.6 channels expressed in Xenopus oocytes. Naunyn Schmiedebergs Arch Pharmacol. 2017 Dec;390(12):1255–1270.
  • Fukuda K-I. Diagnosis and treatment of abnormal dental pain. J Dent Anesth Pain Med. 2016;16(1):1–8.
  • Umemura E, Ito M, Tokura T, et al. The treatment pathway of chronic orofacial pain triggered by dental treatment – relieving effect and concurrent depressive symptoms of duloxetine treatment. Int J Oral Maxillofacial Surg. 2015;44:e153–e155.
  • Thibaut F. Anxiety disorders: a review of current literature. Dialogues Clin Neurosci. 2017 Jun;19(2):87–88.
  • Ashton H. The diagnosis and management of benzodiazepine dependence. Curr Opin Psychiatry. 2005 May;18(3):249–255.
  • Tinastepe N, Tinastepe OK. Neuropathic pain after dental treatment/dental tedaviler sonrasi olusan noropatik agrilar. Agri. 2013;25(1):1–6.
  • Ireland R. The Oxford Dictionary of Dentistry. Oxford, UK: Oxford University Press; 2010. p. 11-12.
  • Betts NJ, Makowski G, Shen YH, et al. Evaluation of topical viscous 2% lidocaine jelly as an adjunct during the management of alveolar osteitis. J Oral Maxillofac Surg. 1995 Oct;53(10):1140–1144.
  • Ali K. Alveolar osteitis: what’s in a name? Br Dent J. 2016 Nov 4;221(11):535.
  • Kolokythas A, Olech E, Miloro M. Alveolar osteitis: a comprehensive review of concepts and controversies. Int J Dent. 2010;2010:249073.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.